Concurrent Technologies PLC Issue of Share options and PDMR dealing

RNS Number : 1440S

Concurrent Technologies PLC

03 January 2025

 

3 January 2025

 

Concurrent Technologies Plc

(the 'Company')

 

Issue of Share options and PDMR dealing

 

The Board of Concurrent Technologies Plc (AIM:CNC) announces that, on 3 January 2025, the Company granted share options (the "Share Options") of 24,194 ordinary shares of 1p each in the share capital of the Company to two employees.

 

All the Share Options are granted under the Concurrent Technologies PLC Long Term Incentive Plan and have an exercise price of 1 pence and are subject to performance conditions linked to the increase in basic earnings per Ordinary Share for the complete years commencing with 1^st January 2025 and ending with the year ending 31^st December 2027.

 

Enquiries:

Concurrent Technologies Plc Miles Adcock - CEO Kim Garrod - CFO	[phone]
Alma Strategic Communications Josh Royston Hannah Campbell Will Merison	[phone]
Cavendish Capital Markets Limited (NOMAD) Neil McDonald Peter Lynch	[phone] [phone]

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded Plug In Cards (PICs) and Systems for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors.  The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems.  The products are sold world-wide.

For more information on Concurrent Technologies Plc and its products please visit www.concurrent.tech

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

IOEBRGDBRDGDGUX